EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development

Shaimaa A Gad, Bryan Bridgeman iD, Kyle Boedeker, Xianzhong Ding, Wei Qiu iD

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.70021 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Shaimaa A Gad and 4 co-authors. Institution: Departments of Surgery, Pathology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA. Major MEDLINE topics: Monocarboxylic Acid Transporters, Carcinoma, Hepatocellular, Symporters, Liver Neoplasms. Cited 4 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCI NIH HHS, NIAAA NIH HHS, This study was supported by National Cancer Institute, the Richard A. Perritt Charitable Foundation, and National Institute on Alcohol Abuse and Alcoholism..

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Hepatocellular carcinoma (HCC) is the most prevalent type of liver cancer and the deadliest liver disease. It is imperative to understand the underlying molecular mechanisms involved in the development of HCC. Monocarboxylate transporter‐1 (MCT1) is a proton‐coupled protein that facilitates the bidirectional transport of monocarboxylates, such as lactate and pyruvate, across the plasma membrane to maintain the cellular metabolism and energy supply. MCT1 was found to be upregulated in human HCC specimens, and its inhibition reduced xenograft tumor growth. However, the role of MCT1 in HCC remains to be further investigated using immune‐competent in vivo models. To better understand the role of MCT1 in HCC, we established liver‐specific MCT1 knockout mice. We found that deletion of MCT1 in liver cells did not affect morphology, proliferation, or apoptosis. DEN/CCl4 model, where a single injection of DEN is followed by repeated injections of CCl4, was used to induce HCC in mice. Intriguingly, we found that liver‐specific knockout of MCT1 was not sufficient to reduce the size or count of DEN/CCl4‐induced liver tumors. In addition, we used immunohistochemical staining to evaluate the expression of Ki67, collagen A1, and myeloperoxidase, and we found that MCT1 knockout was not able to hinder the proliferation, fibrosis, and inflammation in the DEN/CCl4‐induced HCC tumors. In conclusion, MCT1 is dispensable for HCC development, and its deletion was insufficient to alleviate the phenotypic repercussions of HCC tumors in the DEN/CCl4‐induced HCC model.

Subjects

MeSH terms (MEDLINE)

Monocarboxylic Acid TransportersCarcinoma, HepatocellularSymportersLiver NeoplasmsAnimalsMiceHumansMice, KnockoutCell ProliferationApoptosisMaleDiethylnitrosamineLiverGene Expression Regulation, NeoplasticMonocarboxylate Transport Protein 1

Author keywords

dispensablehepatocellular carcinomametabolismmonocarboxylate transporter 1

Substances

Monocarboxylic Acid TransportersSymportersDiethylnitrosamineMonocarboxylate Transport Protein 1

Authors and institutions

  • Departments of Surgery, Pathology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.
  • Departments of Cancer Biology, Pathology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.
  • Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Center, Egypt.
  • Department of Pathology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.

ORCID profiles: Bryan Bridgeman, Wei Qiu

Funding

  • NCI NIH HHS
  • NIAAA NIH HHS
  • This study was supported by National Cancer Institute, the Richard A. Perritt Charitable Foundation, and National Institute on Alcohol Abuse and Alcoholism.
  • National Cancer Institute

Cite

APA

Gad, S. A., Bridgeman, B., Boedeker, K., Ding, X., & Qiu, W. (2025). Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70021

Vancouver

Gad SA, Bridgeman B, Boedeker K, Ding X, Qiu W. Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70021

BibTeX
@article{Gad2025,
  author = {Gad, Shaimaa A and Bridgeman, Bryan and Boedeker, Kyle and Ding, Xianzhong and Qiu, Wei},
  title = {Monocarboxylate Transporter‐1 Is Dispensable for Hepatocellular Carcinoma Development},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.70021}
}
Start for free →